Table 1b.
Feature | Total | Nun-progressor | Progressor | Value - p | ||
---|---|---|---|---|---|---|
chi-squared | log-rank | t-test/U-test | ||||
No. of patients | 95 | 71 | 24 | |||
Vegf-A: | ||||||
Negative | 49 (51.6%) | 37 | 12 | 0.858 | 0.837 | / |
Positive | 46 (48.4%) | 34 | 12 | |||
Glut1: | ||||||
Negative | 41 (43.2%) | 35 | 6 | 0.039 | 0.039 | / |
Positive | 54 (56.8%) | 36 | 18 | |||
E-cadherin: | ||||||
Negative | 52 (54.7%) | 40 | 12 | 0.590 | 0.487 | / |
Positive | 43 (45.3%) | 31 | 12 | |||
Cox-2 | ||||||
Negative | 66 (69.5%) | 48 | 18 | 0.496 | 0.547 | / |
Positive | 29 (30.5%) | 23 | 6 | |||
Tenascin-C: | ||||||
Negative | 50 (52.6%) | 35 | 15 | 0.264 | 0.332 | / |
Positive | 45 (47.4%) | 36 | 9 | |||
Tigar: | ||||||
Negative | 30 (31.6%) | 22 | 8 | 0.831 | 0.848 | / |
Positive | 65 (68.4%) | 49 | 16 |